Biological & New Pharmaceutical Industry

In 2020, the added value of industrial enterprises above designated size rose by 0.3 percent year on year, and the output value of the industry exceeded RMB 60 billion. The technology of such protein drugs as recombinant human granulocyte-macrophage colony-stimulating factor and its market share took the lead in China. In addition, bio-pharmaceutical technologies such as an Escherichia coli-derived virus-like particle-based vaccine, a recombinant hepatitis E vaccine, and a recombinant human papillomavirus vaccine all held world leading positions.

Advanced Equipment Manufacturing Industry

In 2020, the output of industrial companies with annual revenue of more than RMB 20 million increased by 1.1 percent year on year, exceeding RMB 870 billion. The production and sale of loaders, medium and large-sized buses, automobile steel wheels, joint bearings, road rollers, and small and medium-sized electrical machinery are at the forefront of advanced equipment manufacturing growth in China.